Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Prism Medical & Design Secures CE Mark for Its ProteXsure Safety Capsule System
Prism Medical Nabs CE Mark for ProteXsure Safety Capsule System. Prism Medical has secured the CE mark for its ProteXsure Safety Capsule System, intended for the prevention of needle stick injuries. The approval is the first indication for the company’s Prism platform. - March 24, 2016 - Prism Medical & Design
Best Health Care Website to be Named by Web Marketing Association in 20th Annual WebAward Competition
The best healthcare websites in the world will be named as part of the Web Marketing Association's 20th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. - March 18, 2016 - Web Marketing Association
Sheng Lin‐Gibson at NIST, to Present at Stem Cell Summit 2016
Sheng Lin‐Gibson, at the National Institute of Standards and Technology of the Federal Agency, will give a presentation at GTCbio’s Stem Cell Summit 2016. - March 17, 2016 - GTCbio
Roderick Hubbard, Vernalis to Give Presentation at GTCbio’s Kinase Inhibitors Conference
Roderick Hubbard at Vernalis will discuss, “Strategies and Outcomes for Fragments for Kinases” at GTCbio’s Kinase Inhibitors Design & Screening Conference - March 17, 2016 - GTCbio
Roderick Hubbard, Vernalis to Give Presentation at GTCbio’s Med Chem Conference
Roderick Hubbard at Vernalis will discuss, “Strategies and Outcomes for Fragments for Kinases” at GTCbio’s Med Chem Conference. - March 17, 2016 - GTCbio
NSF Funds NanoHybrids’ Improved Chemotherapy Delivery Platform
NSF SBIR grant to be used to advance nanoparticle platform for safe, effective, and controlled cancer drug delivery. - March 16, 2016 - NanoHybrids
Tabula Rasa HealthCare CIO Receives 2016 Executive Management Award
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
AdvantaPure(R) Introduces BioClosure(R) System Assemblies That Reduce Assembly Time, Protect Product Integrity and Decrease Contamination Risks
Single-Use components supplier AdvantaPure announces the availability of BioClosure System Assemblies. The ready-to-use, closed container systems are designed to save customers time and expense in their bioprocess applications by eliminating cleaning validations, reducing the need for multiple inventoried parts, and assembling onsite. The Single-Use assemblies also help decrease contamination risks. Applications include aseptic sampling, cell growth, filling, process R&D and cold storage. - March 10, 2016 - AdvantaPure
Spaulding Clinical Research, a Full-Service CRO to Present at the American Society for Clinical Pharmacology and Therapeutics' (ASCPT) 2016 Annual Meeting
Spaulding Clinical Research, LLC, a full-service CRO announced today that they will be in attendance at the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2016 Annual Meeting. The event is scheduled to take place at the Hilton Bayfront in San Diego, California a from... - March 05, 2016 - Spaulding Clinical Research, LLC
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
Executive Search Firm Informs Readers of 2024 Projected Market Increase Spending for Vasculitis to Reach Upwards of $588 Million
Berke Executive Search, an expert biotech executive search firm, discusses a report with market projections for Vasculitis - a condition involving inflammation of the blood vessels - is expected to reach upwards of $588 million by 2024. This is up from the $342 million in 2014, with a compound annual growth rate (CAGR) of 5.1 percent. - February 25, 2016 - Berke Executive Search
Occammd Appoints New Director of Strategic Alliances
Occammd, a leader in medical and military device design and development, announced today that Chris Carter has joined the firm to further expand their growing portfolio of local and regional clients and partnerships. Mr. Carter contributes a wealth of experience within the industry, having spent... - February 20, 2016 - occammd
MEDLAB Asia Pacific Organized by Informa Life Sciences Exhibitions Unveils the Latest Laboratory Technologies
The ultimate platform for medical laboratory professionals to network and do business - February 20, 2016 - Informa Life Sciences Exhibitions
Je H. Lee from Cold Springs Harbor Laboratory Will Discuss, “Spatial Transcriptomics and Beyond” at GTCbio’s 6th Next Generation Sequencing
Je H. Lee, Assistant Professor at Cold Springs Harbor Laboratory will discuss, “Spatial Transcriptomics and Beyond” at GTCbio’s 6th Next Generation Sequencing to be held on May 25-26, 2016 in Boston, MA. The Lee lab at CSHL is advancing in situ technologies, originally developed... - February 18, 2016 - GTCbio
Alan Wright, CMO of Roche Diagnostics, to Keynote at Biomarkers Summit 2016
Alan Wright, CMO of Roche Diagnostics, will give a keynote presentation on, “Creating Personalized Diagnostics Ecosystems” at Biomarkers Summit 2016. - February 18, 2016 - GTCbio
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
Baruch S. Blumberg Institute and The Commonwealth Medical College to Hold Open House for Master of Biomedical Science Degree Program
Students can learn more about the life sciences graduate program offered in Doylestown. - February 11, 2016 - Hepatitis B Foundation
NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect
Poriferous, LLC Signs Exclusive Distribution Agreement with Minogue Medical, Inc.
Agreement expands availability of SU-POR products to Canadian Market. - February 03, 2016 - Poriferous LLC
Global Polymerase Chain Reaction (PCR) Market is Projected to Reach US$12 Billion by 2020 - marketinforesearch.com
Global Polymerase Chain Reaction (PCR) market is projected to reach US$12 billion by 2020, growing at a CAGR of 10.1% during the analysis period of 2014-2020 respectively - February 03, 2016 - MarketInfo Research
Eminent Spine® Releases Updated King Cobra® White Paper
After receiving positive feedback from the cervical spine research community at last month’s CSRS meeting, Dr. Stephen Courtney has released the clinical results of his experience with two revolutionary cervical fusion devices. The King Cobra anterior cervical plate and the Copperhead... - February 02, 2016 - Eminent Spine
Eagle Biosciences Announces the Launch of Functional Leptin ELISA
An Esoteric Kit for Measurement of Functional, Receptor Binding Leptin Levels in Serum or Plasma - January 25, 2016 - Eagle Biosciences, Inc.
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC
Crais Management Group Completes Study on the Changing Nature of Medical Device Development
Crais Management Group Completes Study on the Changing Nature of Medical Device Development, Connected Biotech Systems, and Capital and Detail Sales in 2016 Global Healthcare Crais Management Group (CMG LLC) launched a study last year on the changing nature of medical device, biotech, biomedical,... - January 19, 2016 - Crais Management Group, LLC
Recombinant Coagulation Factors Market to Reach $9,939.7 Million by 2020
The growth of this market is primarily attributed to the increasing number of hemophilia patients, growing diagnosis rates, and rising number of research and development on coagulation factors. In addition, increasing prophylactic treatment for hemophilia across the globe is further expected to drive the growth of this market. - January 17, 2016 - Meticulous Research
Drug Safety Company Expands Operations
Drug Safety Navigator, LLC (DSN) Announces Another Expansion in Its Fifth Year of Operation - January 13, 2016 - Drug Safety Navigator, LLC
BÜHLMANN Laboratories Opens North American Affiliate
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - January 11, 2016 - BUHLMANN Diagnostics Corp
Hepatitis B Foundation Leaders Help Shape National Plan to Eliminate Hepatitis B and C
Drs. Robert Gish and Chari Cohen provide expert testimony to the National Academy of Medicine in support of a national strategy to eliminate chronic viral hepatitis in the United States by 2030. - January 10, 2016 - Hepatitis B Foundation
BDA Advises Founder on Sale of Diagnostic Biotech Company CHROMagar SAS
BDA Partners is pleased to announce that the French company CHROMagar SAS, the pioneer in innovative chromogenic culture media solutions, has been sold to a Japanese chemicals company. BDA acted as the exclusive financial advisor to CHROMagar founder and shareholder, Dr. Alain Rambach. Terms of the... - January 06, 2016 - BDA Partners Ltd
The Therapeutic Utility of mRNA for The Expression of Therapeutic Proteins
RNA Therapeutics 2016, 15th & 16th February, Holiday Inn Kensington Forum, London UK - January 06, 2016 - SAE Media Group
Ethos Spa, Skin and Laser Center Announces Availability of Cynosure Elite+ to Treat Laser Hair Removal Patients with All Skin Types
Ethos Spa, Skin and Laser Center has announced today the Cynosure Elite+ aesthetic workstation that can treat all skin types as well as provide faster treatments. The Elite + platform can perform laser hair removal, skin rejuvenation, as well as removal of spider veins. - January 05, 2016 - Ethos Spa
H2Biologics Licenses Worldwide, Exclusive Rights to Develop SD1-Granzyme B Drug Conjugate for Treatment of Mesothelin-Expressing Tumors
H2Biologics announced that it has been granted a worldwide, exclusive license by the Research Development Foundation (RDF) for the use of human granzyme B (GrB), a naturally occurring serine protease, in developing an immunoconjugate with a human single domain antibody (SD1) that targets... - December 31, 2015 - H2Biologics Inc.
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
Global Compounding Pharmacies Market to Reach US$ 9.7 Bn by 2021: Persistence Market Research
Globally, compounding pharmacies are estimated to account for market value of US$ 6,786 Mn by the end of 2015, and is projected to witness stable growth across all global regions due to rising demand for personalized medicines from customers. - November 26, 2015 - Persistence Market Research
Dr Sandip Patel to Speak on Biomarkers for Cancer Immunotherapy: Beyond PD-L1
Dr Sandip Patel - Assistant Professor, Cancer Immunotherapy Program at UC San Diego Moores Cancer Centre will present at the Biomarker Conference to be held on 18–19 February 2016 in San Diego, USA. - November 22, 2015 - MarketsandMarkets
Altogen Biosystems In Vivo Pancreas Kit Has Applications for Diabetes Mellitus and Pancreatic Cancer
As featured by Science magazine, Altogen Biosystems offers a popular line of in vivo transfection reagent kits that include polymer, liposome, nanoparticle and PEG-liposome-based in vivo transfection kits as well as in vivo kits dedicated to targeting tissues, one of which is highlighted here: the... - November 21, 2015 - Altogen Biosystems
Two Research Reports Cite HemogloBind™ for Highly Efficient Sample Preparation
Biotech Support Group reports on two recent research reports which describe the simplicity and efficiency of their proteomic sample preparation technology for hemoglobin depletion. - November 20, 2015 - Biotech Support Group
BUHLMANN Laboratories Announces New, Direct US Affiliate
BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015 - BUHLMANN Diagnostics Corp
Prosidyan Announces FDA 510(k) Clearance of FIBERGRAFT BG Morsels for Postero-Lateral Spinal Fusion
NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT BG Morsels for Postero-lateral Spinal Fusion. FIBERGRAFT BG Morsels is an ultra-porous Bone Graft Substitute, made entirely... - November 16, 2015 - Prosidyan, Inc.
Global and USA Biosimilar Market: Updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
SMi reports: (2015.11.06, Iselin, New Jersey, USA): Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November - November 08, 2015 - SAE Media Group
PMR: Global Compounding Pharmacies Market to Reach US$ 9.7 Bn by 2021
Asia Pacific is expected to emerge as the market portraying the healthiest growth rates throughout the forecast period. Certain markets in Asia Pacific such as Singapore are estimated to witness double-digit growth rates. - November 07, 2015 - Persistence Market Research
Zenalux Announces Grants from the National Institute of Health for Cancer Screening
Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, has been awarded a grant from the National Institute of Health (NIH) to further develop the Zenascope® to screen for cancer by employing imaging and reducing operator error. Zenalux is also participating in an Academic Industry... - November 06, 2015 - Zenalux Biomedical, Inc.
Immanuel Pathways PACE Chooses CareKinesis for Its Pharmacy Services Provider
CareKinesis partners with health care organizations to provide personalized medication therapy management and pharmacy services for high-risk populations. The results are enhanced medication-related outcomes and greater operational efficiency. - October 22, 2015 - CareKinesis
Altogen Biosystems Develops Powerful In Vivo RNAi Research Tool for Oncology
Lipid-based liposomes of nanometer size are one of the most powerful molecules for delivery of novel therapeutics into target tissues enabling targeted cancer therapeutics. Pharma companies actively investigating new RNAi-based therapeutics where cargo molecules such as a small proteins, DNA,... - October 13, 2015 - Altogen Biosystems
The MCS Group, Inc. Launches New Website
The MCS Group, Inc., a national provider of outsourcing solutions, has launched a completely redesigned corporate website, providing a more engaging user experience with enhanced search and navigation as well as on-page forms, and a more user-friendly interface. - October 12, 2015 - The MCS Group, Inc.
Global 3D Cell Culture Market is Expected to Reach $2,750 Million by 2020
North America dominates the 3D cell culture market in the year 2015, followed by Europe and Asia. Asia is slated to witness the highest growth rate in the coming five years with China, Japan, Taiwan, India, Malaysia, and Singapore witnessing significant growth in the 3D cell culture market, as a result of their economic development, rising awareness regarding cancer in these countries, huge production of drugs in this region, and the growing focus of 3D cell culture players in these markets. - October 11, 2015 - Meticulous Research
Public Health of Castilla La Mancha Opts for the Legipid Rapid Test for Detecting Legionella in Water
The Public Health Laboratories of Castilla La Mancha (Spain) have introduced the Legipid® Legionella Fast Detection kit to determine Legionella in water. This kit was developed by the company Biotica Bioquimica Analitica (www.biotica.es), which belongs to the Science, Technology and Business Park of the Universitat Jaume I (Espaitec). - October 08, 2015 - Biotica Bioquimica Analitica
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals